BR0210817A - Método para a preparação de escitalopram, e, intermediário - Google Patents

Método para a preparação de escitalopram, e, intermediário

Info

Publication number
BR0210817A
BR0210817A BR0210817-8A BR0210817A BR0210817A BR 0210817 A BR0210817 A BR 0210817A BR 0210817 A BR0210817 A BR 0210817A BR 0210817 A BR0210817 A BR 0210817A
Authority
BR
Brazil
Prior art keywords
escitalopram
preparation
citalopram
new
chiral
Prior art date
Application number
BR0210817-8A
Other languages
English (en)
Inventor
Michael Bech Sommer
Ole Nielsen
Hans Petersen
Haleh Ahmadian
Henrik Pedersen
Peter Brosen
Fiona Geiser
James Lee
Geoffrey Cox
Olivier DAPREMONT
Christina Suteu
Sebastian P Assenza
Shankar Hariharan
Usha Nair
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27222518&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0210817(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR0210817A publication Critical patent/BR0210817A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C07C215/32—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton containing hydroxy groups and carbon atoms of two six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"MéTODO PARA A PREPARAçãO DE ESCITALOPRAM, E, INTERMEDIáRIO". Um novo método é proporcionado para a manufatura de escitalopram. O método compreende a separação cromatográfica dos enanciómeros de citalopram ou de um intermediário na produção de citalopram usando uma fase estacionária quiral tal como Chiralpak^ TM^ AD ou Chiralcel^ TM^ OD. Novos intermediários quirais para a síntese de Escitalopram preparados pelo citado método também são proporcionados.
BR0210817-8A 2001-07-13 2002-07-12 Método para a preparação de escitalopram, e, intermediário BR0210817A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200101101 2001-07-13
DKPA200101851 2001-12-11
DKPA200101852 2001-12-11
PCT/DK2002/000491 WO2003006449A1 (en) 2001-07-13 2002-07-12 Method for the preparation of escitalopram

Publications (1)

Publication Number Publication Date
BR0210817A true BR0210817A (pt) 2004-06-22

Family

ID=27222518

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210817-8A BR0210817A (pt) 2001-07-13 2002-07-12 Método para a preparação de escitalopram, e, intermediário

Country Status (28)

Country Link
US (2) US20050065207A1 (pt)
EP (1) EP1409472A1 (pt)
JP (1) JP2004538276A (pt)
KR (4) KR100956260B1 (pt)
CN (2) CN100457746C (pt)
AR (1) AR034759A1 (pt)
AU (1) AU2009200448A1 (pt)
BG (1) BG108572A (pt)
BR (1) BR0210817A (pt)
CA (1) CA2451124C (pt)
CO (1) CO5550496A2 (pt)
EA (1) EA014823B1 (pt)
HR (1) HRPK20031074B3 (pt)
HU (1) HUP0401451A3 (pt)
IL (1) IL159183A0 (pt)
IS (1) IS7064A (pt)
ME (1) MEP2008A (pt)
MX (1) MXPA04000205A (pt)
MY (1) MY144333A (pt)
NO (1) NO328561B1 (pt)
PE (1) PE20030253A1 (pt)
PL (1) PL366383A1 (pt)
RS (1) RS1804A (pt)
TW (1) TWI268926B (pt)
UA (1) UA84258C2 (pt)
UY (1) UY27379A1 (pt)
WO (1) WO2003006449A1 (pt)
ZA (1) ZA200309471B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR040970A1 (es) * 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
US7390913B2 (en) 2002-12-23 2008-06-24 H. Lundbeck A/S Process for the preparation of racemic citalopram diol and/or S- or R-citalopram diols and the use of such diols for the preparation of racemic citalopram, R-citalopram and/or S-citalopram
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
ES2228274B1 (es) * 2003-09-24 2006-06-01 Astur Pharma, S.A. Sintesis quimioenzimatica de (+)-citalopram y (-)-citalopram.
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050196453A1 (en) 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
ITMI20040717A1 (it) 2004-04-09 2004-07-09 Adorkem Technology Spa Procedimento chemo-enzimatico per la preparazione dell'escitalopram
JP2006008603A (ja) * 2004-06-25 2006-01-12 Sumitomo Chemical Co Ltd 光学活性シタロプラムの製造方法、その中間体およびその製造方法
US7989645B2 (en) * 2004-08-23 2011-08-02 Sun Pharma Global Fze Process for preparation of citalopram and enantiomers
US7790935B2 (en) 2004-08-23 2010-09-07 Sun Pharma Global Fze Process for preparation of citalopram and enantiomers
ITMI20041872A1 (it) 2004-10-01 2005-01-01 Adorkem Technology Spa Processo per la preparazione di citalopram e di scitalopram
EP1877394A1 (en) * 2005-04-04 2008-01-16 Jubilant Organosys Limited Process for the preparation of escitalopram or its acid addition salts
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP1954257A4 (en) 2005-10-14 2009-05-20 Lundbeck & Co As H METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION
CN101309924A (zh) * 2005-11-14 2008-11-19 H.隆德贝克有限公司 依地普仑的制备方法
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
PT1988086E (pt) 2007-04-23 2012-02-28 Synthon Bv Processo para a resolução de citalopram via o seu composto tartarato de citalopram enriquecido em (s)
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram
NZ570884A (en) 2007-09-11 2010-03-26 Lundbeck & Co As H Fractionally crystallising 4-[4-(dimethyl amino)-1-(4'-fluorophenyl)-1-hydroxybutyI]-3-(hydroxymethyl)-benzonitrile and manufacturing escitalopram therefrom
US8022232B2 (en) * 2007-09-11 2011-09-20 H. Lundbeck A/S Method for manufacture of escitalopram
CN106568863A (zh) * 2016-11-04 2017-04-19 北京万全德众医药生物技术有限公司 一种用高效液相色谱法分离测定草酸艾司西肽普兰中间体光学异构体的方法
CN107941962A (zh) * 2017-12-28 2018-04-20 北京和合医学诊断技术股份有限公司 检测血液中艾司西酞普兰药物含量的液相色谱分析方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
JP3010816B2 (ja) 1991-08-22 2000-02-21 ダイセル化学工業株式会社 光学分割における光学異性体と溶媒との回収方法、溶媒の循環使用方法、および光学異性体の再利用方法
US5514818A (en) * 1993-09-17 1996-05-07 Daicel Chemical Industries, Ltd. Resolution of stereoisomers of aliphatic epoxides
US5889180A (en) * 1997-11-10 1999-03-30 Uop Llc Use of small pore silicas as a support for a chiral stationary phase
NL1017415C1 (nl) * 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
US6764200B1 (en) * 2003-01-15 2004-07-20 Hsiang Lan Wu Liu Decorative lantern

Also Published As

Publication number Publication date
PL366383A1 (en) 2005-01-24
MEP2008A (xx) 2010-02-10
CO5550496A2 (es) 2005-08-31
IL159183A0 (en) 2004-06-01
UY27379A1 (es) 2003-02-28
CN1527825A (zh) 2004-09-08
EA014823B1 (ru) 2011-02-28
EP1409472A1 (en) 2004-04-21
JP2004538276A (ja) 2004-12-24
HUP0401451A3 (en) 2007-05-29
HRPK20031074B3 (en) 2009-10-31
MY144333A (en) 2011-08-29
ZA200309471B (en) 2004-12-06
HK1069386A1 (zh) 2005-05-20
US20050065207A1 (en) 2005-03-24
US20110065938A1 (en) 2011-03-17
CA2451124A1 (en) 2003-01-23
EA200400177A1 (ru) 2004-06-24
HUP0401451A2 (hu) 2004-11-29
CA2451124C (en) 2009-11-24
MXPA04000205A (es) 2004-03-18
CN100457746C (zh) 2009-02-04
KR100956260B1 (ko) 2010-05-07
HRP20031074A2 (en) 2004-04-30
KR20040030046A (ko) 2004-04-08
RS1804A (sr) 2006-12-15
WO2003006449A1 (en) 2003-01-23
CN101265199A (zh) 2008-09-17
NO328561B1 (no) 2010-03-22
PE20030253A1 (es) 2003-03-19
KR20100036387A (ko) 2010-04-07
KR20080108629A (ko) 2008-12-15
AU2009200448A1 (en) 2009-03-05
UA84258C2 (en) 2008-10-10
BG108572A (bg) 2005-03-31
AR034759A1 (es) 2004-03-17
IS7064A (is) 2003-12-04
NO20040027L (no) 2004-01-05
KR20080108628A (ko) 2008-12-15
TWI268926B (en) 2006-12-21

Similar Documents

Publication Publication Date Title
BR0210817A (pt) Método para a preparação de escitalopram, e, intermediário
WO2002055519A3 (en) Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
BR9809279A (pt) Procedimento para produção de uma fração de blocos g e/ou blocos m a partir de alginato
SE9904850D0 (sv) Novel process and intermediates
DE502004011239D1 (de) Verfahren zur dehydratisierung substituierter 4-dimethylamino-2-aryl-butan-2-ol-verbindungen und verfahren zur herstellung substituierter dimethyl-(3-katalyse
WO2006047288A3 (en) Asymmetric synthesis of dihydrobenzofuran derivatives
HUP0400293A3 (en) Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram
WO2003011849A8 (en) Process for the production of beraprost and its salts
DK1127886T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
BR9903274A (pt) Processo para isolar vitamina d3
DK1135517T3 (da) Produktionen af ascorbinsyre ved at anvende gær
ES2190266T3 (es) Ligandos quirales para catalisis asimetrica.
BR0004965A (pt) Processo para preparação de compostos de cromano esterificados
WO2006036949A3 (en) Preparation of n-aryl pyridones
Bringmann et al. Atropo-enantioselective reduction of configurationally unstable biaryl lactones with BINAL-H
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
MY120471A (en) Method for producing enantiomer-free n-methyl-n-[(1s)-1-phenyl-2-((3s)-3-hydroxypyrolidine-1-yl) ethyl]-2, 2-diphenylacetamide.
AR037046A1 (es) Un procedimiento para la preparacion de tetralona racemica opticamente pura o enriquecida
BR9909151A (pt) processos para preparação de intermediários
AU4135999A (en) Chiral stationary phases for enantiomers separation and their preparation
DE602005013681D1 (de) Verfahren zur herstellung von escitalopram
ATE252566T1 (de) Herstellung von 2-(2-arylmorpholin-2- yl)ethanolderivaten und zwischenprodukte
AU1517601A (en) Method for production of benzofuranone oximes
BR9908511A (pt) Processo para a preparação de um composto, e, composto

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: C07D 307/87, C07B 57/00

Ipc: C07D 307/87 (2011.01), C07B 57/00 (2011.01), A61P

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.